Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$7.8K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
2 of 5 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 28 business days late.
The 13 most recent Form 4 transactions.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
| Mar 3 | ATHA | Athira Pharma, Inc. | MEXER◆ | 3,900 | — | — | — | Open the original filing on SEC.gov |
| Mar 3 | ATHA | Athira Pharma, Inc. | MEXER | 3,900 | — | — | +30.3% | Open the original filing on SEC.gov |
| Jan 2 | ATHA | Athira Pharma, Inc. | SSELL | 297 | $6.88 | $2K | -2.3% | Open the original filing on SEC.gov |
| Dec 31, 2025 | ATHA | Athira Pharma, Inc. | MEXER◆ | 1,236 | — | — | — | Open the original filing on SEC.gov |
| Dec 31, 2025 | ATHA | Athira Pharma, Inc. | MEXER | 1,236 | — | — | +10.4% | Open the original filing on SEC.gov |
| Dec 24, 2025 | ATHA | Athira Pharma, Inc. | AGRANT◆ | 34,358 | — | — | — | Open the original filing on SEC.gov |
| Nov 18, 2025 | ATHA | Athira Pharma, Inc. | AGRANT | 1,000 | $2.31 | $2.3K | +9.2% | Open the original filing on SEC.gov |
| Jul 1, 2025 | ATHA | Athira Pharma, Inc. | SSELL | 2,897 | $0.2935 | $850 | -2.6% | Open the original filing on SEC.gov |
| Jun 30, 2025 | ATHA | Athira Pharma, Inc. | MEXER◆ | 12,359 | — | — | — | Open the original filing on SEC.gov |
| Jun 30, 2025 | ATHA | Athira Pharma, Inc. | MEXER | 12,359 | — | — | +12.4% | Open the original filing on SEC.gov |
| May 19, 2025 | ATHA | Athira Pharma, Inc. | AGRANT | 10,000 | $0.2312 | $2.3K | +11.2% | Open the original filing on SEC.gov |